Haematological Malignancies Terminated Phase 2 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

Also known as: Hematological Malignancies / Hematological Malignancy / Haematological Malignancy / Hematologic malignancy / Hematologic Neoplasms

IndicationStatusPhase
DBCOND0046524 (Haematological Malignancies)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00506948Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)Treatment